Ground-level proof points accumulating: management narrates several small, named, recent wins and treats them as the lea
The model's full reasoning — Q4 2021 call → NOWe need to determine if the transcript contains at least three distinct, named or individually identifiable episodes from the recent period, and if management explicitly connects these episodes into a building pattern that is still early. Let's scan the transcript for specific episodes: 1. "We completed alternative fatty acid production and saw the first sales of our new ALTAVEG product." - This is a specific product launch with first sales. 2. "We continue to assess other feedstocks and expect commercial sales to grow this year." - That's forward-looking, not an episode. 3. "We also sold non-CTO based alternative fatty acids as well as alternative fatty acid derivatives in Q4." - That's a specific sale. 4. "We remain excited about the product's potential to further grow in the auto industry and support electric vehicles." - Not an episode. 5. "We further improved our sustainable value proposition... a recently completed third-party product study shows at WestRez, our Performance Chemicals Adhesive Technology has a 62% lower in-life carbon footprint than petroleum-based alternatives." - That's a study, not an episode. 6. "We increased the number of USDA certified bio-based products in our portfolio by 50% bringing our total of 34 products that are recognized." - That's a count, not an episode. Now, in the Performance Chemicals section: - "Industrial Specialty sales increased 28% versus the prior-year quarter with strong performance across all markets. Sales growth in adhesives, TOFA and disbursements all increased by over 30% versus Q4 2020. Oilfield applications delivered particularly strong growth with sales up over 50% in the quarter due to the increase in North American drilling activity and our growth in sales to the Middle East." - That's aggregate, not specific episodes. - "Our agricultural chemical business saw increased demand due to further adoption of our sustainable technologies across the market segment. We continue to see positive outcomes from late-stage field trials underway across major agricultural customers." - That's a mention of field trials, but not a specific episode. - "We also sold non-CTO based alternative fatty acids as well as alternative fatty acid derivatives in Q4." - That's a specific sale, but it's a bit vague. - "Pavement Technologies had a record Q4 with sales up 11%, mainly driven by pavement preservation volumes.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| AU | AngloGold Ashanti's | Q2 2018 | 2018-08-20 | B |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
AU · Q2 2018 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...YES The transcript shows multiple specific, recent operational episodes: Kibali’s underground ramp-up with automated ore handling system and vertical shaft integration; Iduapriem’s CIL tank conversion and grade/tonnage gains; Sunrise Dam’s Recovery Enhancement Project plus new mining strategies; Tropicana’s second 6-MW ball mill installation; Siguiri’s CIL circuit milestone; and 338 tracked Operational Excellence projects.
BXP · Q1 2022 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...YES The transcript shows multiple distinct, named episodes from the recent period: the 73,000 sq ft recapture/release at 77 CityPoint with a 15% rent increase and 7.
CRGO · Q1 2024 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...